• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于使用酶抑制剂研究脑内γ-氨基丁酸(GABA)的合成与利用

On the use of enzyme inhibitors to study the synthesis and utilization of brain GABA.

作者信息

Lindgren S, Andén N E

出版信息

Acta Pharmacol Toxicol (Copenh). 1984 Jul;55(1):41-9. doi: 10.1111/j.1600-0773.1984.tb01960.x.

DOI:10.1111/j.1600-0773.1984.tb01960.x
PMID:6087618
Abstract

Changes in the GABA concentration in different parts of the rat brain were studied following inhibition of the glutamic acid decarboxylase or the GABA-alpha-ketoglutaric acid aminotransferase. The GABA concentration was reduced by the decarboxylase inhibitors 4-deoxypyridoxine and isoniazid, but not by 3-mercaptopropionic acid and DL-allylglycine. The aminotransferase inhibitor gamma-acetylenic GABA increased the concentration of GABA and this effect was markedly inhibited by 3-mercaptopropionic acid and partly by 4-deoxypyridoxine and isoniazid. The 4-deoxypyridoxine-induced decrease in GABA concentration was approximately maximal after 400 mg/kg intraperitoneally and 90 min. The brain DOPA decarboxylase activity in vivo was not inhibited by 4-deoxypyridoxine. The GABA concentration in the substantia nigra was reduced by 75 per cent 4 days after section of the striato-nigral GABA neurones. In the denervated substantia nigra, 4-deoxypyridoxine did not change the concentration of GABA whereas the effect of gamma-acetylenic GABA was reduced by 70 per cent.

摘要

在抑制谷氨酸脱羧酶或γ-氨基丁酸-α-酮戊二酸转氨酶后,研究了大鼠脑不同部位γ-氨基丁酸(GABA)浓度的变化。脱羧酶抑制剂4-脱氧吡哆醇和异烟肼可降低GABA浓度,但3-巯基丙酸和DL-烯丙基甘氨酸则无此作用。转氨酶抑制剂γ-乙炔基GABA可增加GABA浓度,且该作用被3-巯基丙酸显著抑制,被4-脱氧吡哆醇和异烟肼部分抑制。腹腔注射400mg/kg 4-脱氧吡哆醇90分钟后,其诱导的GABA浓度降低作用接近最大。4-脱氧吡哆醇对体内脑多巴脱羧酶活性无抑制作用。切断纹状体-黑质GABA神经元4天后,黑质中GABA浓度降低75%。在去神经支配的黑质中,4-脱氧吡哆醇不改变GABA浓度,而γ-乙炔基GABA的作用则降低70%。

相似文献

1
On the use of enzyme inhibitors to study the synthesis and utilization of brain GABA.关于使用酶抑制剂研究脑内γ-氨基丁酸(GABA)的合成与利用
Acta Pharmacol Toxicol (Copenh). 1984 Jul;55(1):41-9. doi: 10.1111/j.1600-0773.1984.tb01960.x.
2
Effect of the normal nerve impulse flow on the synthesis and utilization of GABA in the rat substantia nigra.
J Neural Transm. 1985;61(1-2):21-34. doi: 10.1007/BF01253048.
3
Regional differences in the changes in rat brain GABA concentrations post mortem and following inhibition of the synthesis and metabolism.大鼠死后以及合成与代谢受到抑制后脑内γ-氨基丁酸(GABA)浓度变化的区域差异。
Pharmacol Toxicol. 1987 May;60(5):393-6. doi: 10.1111/j.1600-0773.1987.tb01534.x.
4
Effects of GABAergic drugs on the GABA turnover in the substantia nigra and the corpus striatum of the rat.
J Neural Transm. 1987;69(1-2):33-46. doi: 10.1007/BF01244095.
5
The effect of antivitamin B6 administration on gamma-aminobutyric acid metabolism in retina and electroretinogram.给予抗维生素B6对视网膜中γ-氨基丁酸代谢及视网膜电图的影响。
J Nutr Sci Vitaminol (Tokyo). 1980;26(1):25-32. doi: 10.3177/jnsv.26.25.
6
Effect of microinjections of gamma-vinyl GABA or isoniazid into substantia nigra on the development of amygdala kindling in rats.向大鼠黑质微量注射γ-乙烯基γ-氨基丁酸或异烟肼对杏仁核点燃发展的影响。
Exp Neurol. 1987 Mar;95(3):622-38. doi: 10.1016/0014-4886(87)90304-9.
7
Use of inhibitors of gamma-aminobutyric acid (GABA) transaminase for the estimation of GABA turnover in various brain regions of rats: a reevaluation of aminooxyacetic acid.使用γ-氨基丁酸(GABA)转氨酶抑制剂评估大鼠不同脑区的GABA周转率:对氨氧乙酸的重新评估
J Neurochem. 1989 Dec;53(6):1737-50. doi: 10.1111/j.1471-4159.1989.tb09239.x.
8
Iron concentration reduced in ventral pallidum, globus pallidus, and substantia nigra by GABA-transaminase inhibitor, gamma-vinyl GABA.γ-乙烯基 GABA(一种γ-氨基丁酸转氨酶抑制剂)可降低腹侧苍白球、苍白球和黑质中的铁浓度。
Brain Res. 1985 Sep 2;342(1):18-25. doi: 10.1016/0006-8993(85)91348-4.
9
Seizures induced by allylglycine, 3-mercaptopropionic acid and 4-deoxypyridoxine in mice and photosensitive baboons, and different modes of inhibition of cerebral glutamic acid decarboxylase.烯丙基甘氨酸、3-巯基丙酸和4-脱氧吡哆醇在小鼠和光敏狒狒中诱发的癫痫发作,以及脑谷氨酸脱羧酶的不同抑制模式。
Br J Pharmacol. 1973 Sep;49(1):52-63. doi: 10.1111/j.1476-5381.1973.tb08267.x.
10
In vivo action of enzyme-activated irreversible inhibitors of glutamic acid decarboxylase and gamma-aminobutyric acid transaminase in retina vs. brain.谷氨酸脱羧酶和γ-氨基丁酸转氨酶的酶激活不可逆抑制剂在视网膜与大脑中的体内作用。
J Pharmacol Exp Ther. 1986 Aug;238(2):508-14.

引用本文的文献

1
Effect of the normal nerve impulse flow on the synthesis and utilization of GABA in the rat substantia nigra.
J Neural Transm. 1985;61(1-2):21-34. doi: 10.1007/BF01253048.
2
The specific protective effect of diazepam and valproate against isoniazid-induced seizures is not correlated with increased GABA levels.地西泮和丙戊酸盐对异烟肼诱发癫痫的特异性保护作用与γ-氨基丁酸(GABA)水平升高无关。
J Neural Transm. 1985;63(2):169-89. doi: 10.1007/BF01252616.
3
Effects of KCl-induced depolarization on the GABA concentration in the corpus striatum and in the substantia nigra.
J Neural Transm. 1986;66(3-4):161-70. doi: 10.1007/BF01260911.
4
Lack of effects of apomorphine, haloperidol and clozapine on the synthesis and utilization of brain GABA.
J Neural Transm. 1987;69(1-2):47-57. doi: 10.1007/BF01244096.
5
Evaluation of the anticonvulsant and biochemical activity of CGS 8216 and CGS 9896 in animal models.CGS 8216和CGS 9896在动物模型中的抗惊厥及生化活性评估。
J Neural Transm. 1988;71(1):11-27. doi: 10.1007/BF01259406.
6
Adaptation of the GABAA-receptor complex in rat brain during chronic elevation of GABA by ethanolamine O-sulphate.乙醇胺 O-硫酸盐使大鼠脑内 GABA 长期升高过程中 GABAA 受体复合物的适应性变化
Br J Pharmacol. 1987 Jul;91(3):617-25. doi: 10.1111/j.1476-5381.1987.tb11255.x.
7
Effects of GABAergic drugs on the GABA turnover in the substantia nigra and the corpus striatum of the rat.
J Neural Transm. 1987;69(1-2):33-46. doi: 10.1007/BF01244095.
8
GABAergic drugs and conflict behavior in the rat: lack of similarities with the actions of benzodiazepines.大鼠体内的γ-氨基丁酸能药物与冲突行为:与苯二氮䓬类药物作用缺乏相似性
Naunyn Schmiedebergs Arch Pharmacol. 1991 Sep;344(3):314-22. doi: 10.1007/BF00183006.